Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Topic prioritisation
Topic prioritisation
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Decision date
Decision date
From date
To date
Apply date filters
Prioritisation routing
Prioritisation routing
None selected (376)
Decision
Decision
Awaiting decision (51)
Further information required (26)
Not selected (295)
Apply filters
Showing 221 to 230 of 376
Sort by
Decision date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Topic prioritisation
Title
Prioritisation routing
Decision
Decision date
Bronchoscopic intrabullous autologous blood instillation (BIABI) for the therapy of Emphysema: intractable with pneumothorax, COPD & Lung cancer, patients requiring lung biopsy
None selected
Not selected
23 February 2023
Intravenous infusion of mesenchymal stromal cells in patients with severe recalcitrant psoriasis
None selected
Not selected
23 February 2023
Emicizumab for preventing bleeding episodes in people with mild or moderate haemophilia A [ID5098]
None selected
Not selected
16 February 2023
Baricitinib for treating moderate to severe atopic dermatitis in children and young people aged 2 to 17 [TSID10639]
None selected
Not selected
14 February 2023
Ceftobiprole medocaril for treating community- or hospital-acquired pneumonia in people 3 months to 17 years [TSID11819]
None selected
Not selected
9 February 2023
Subcutaneous belimumab for treating systemic lupus erythematosus in children aged 5 to 17 [TSID11828]
None selected
Not selected
7 February 2023
EUS guided portal pressure measurement
None selected
Awaiting decision
1 February 2023
Bardoxolone methyl for treating chronic kidney disease in people 12 years and over with Alport syndrome [TSID9998]
None selected
Not selected
23 January 2023
Aflibercept for untreated diabetic macular oedema [TSID10621]
None selected
Not selected
16 January 2023
High-dose aflibercept for treating wet age-related macular degeneration [TSID10590]
None selected
Not selected
16 January 2023
Previous page
1
…
21
22
Current page
23
24
25
…
38
Page
23
of
38
Next page
Results per page
10
25
50
All
Back to top